Akinci Devrim, Akhan Okan, Ozmen Mustafa, Peynircioğlu Bora, Ozkan Orhan
Hacettepe Universitesi Tip Fakültesi, Radyoloji Anabilim Dali, Ankara, Turkey.
Tani Girisim Radyol. 2004 Dec;10(4):323-7.
To evaluate the effectiveness of the percutaneous cholecystostomy with the follow up results of our patients.
We retrospectively evaluated the medical records of 37 patients who underwent percutaneous cholecystostomy. Eighteen female and 19 male patients were included into this study between the ages of 7 and 88 years. All of our patients had acute cholecystitis or eventually developed acute cholecystitis except one. Seven year old male patient with Non-Hodgkin lymphoma underwent percutaneous cholecystostomy due to elevation of liver function tests and direct bilirubin. Since he had dilated intrahepatic biliary ducts due to a lymphadenopathy compression at portal hilus, percutaneous cholecystostomy was performed to decompress the biliary system to decrease the bilirubin and liver function tests to normal levels for initiating appropriate chemotherapy protocol. All the procedures were carried under fluoroscopic and sonographic guidance through transhepatic or transperitoneal approach with 6 to 10 F drainage catheters.
Recovery from the acute cholecystitis symptoms was achieved in 31 patients (86%) in follow-up. No procedure-related mortality was observed. The only major complication was intraperitoneal bleeding due to underlying coagulopathy which was treated with blood transfusion. Eight patients (21.6%) died in 30 days after the percutaneous intervention procedure. In the patient with Non-Hodgkin lymphoma at the age of 7, however, the procedure to decrease the bilirubin levels was successful and chemotherapy was given subsequently; he had died after 31 days due to his aggressive primary disease. Catheterization times were between 2 days and 60 days due to accompanied diseases. Six patients (16.7%) were finally undergone to cholecystectomy after the risks for surgery had been reduced. ERCP was performed in 2 patients (5.6%) for stone extraction from common bile duct. Eighteen patients (50%) were recovered from the acute illness and following the control cholangiograms, catheters were taken out consequently.
Percutaneous cholecystostomy under ultrasonographic and fluoroscopic guidance is a cost-effective, easy to perform and reliable procedure with low complication and high success rates for critically ill patients with acute cholecystitis.
通过对患者的随访结果评估经皮胆囊造瘘术的有效性。
我们回顾性评估了37例行经皮胆囊造瘘术患者的病历。本研究纳入了18名女性和19名男性患者,年龄在7岁至88岁之间。除1例患者外,所有患者均患有急性胆囊炎或最终发展为急性胆囊炎。一名7岁的非霍奇金淋巴瘤男性患者因肝功能检查和直接胆红素升高接受了经皮胆囊造瘘术。由于他因肝门部淋巴结病压迫导致肝内胆管扩张,故行经皮胆囊造瘘术以减压胆道系统,使胆红素和肝功能检查恢复至正常水平,从而启动适当的化疗方案。所有操作均在透视和超声引导下,通过经肝或经腹途径,使用6至10F引流导管进行。
随访中31例患者(86%)急性胆囊炎症状得到缓解。未观察到与操作相关的死亡病例。唯一的主要并发症是因潜在凝血功能障碍导致的腹腔内出血,经输血治疗。8例患者(21.6%)在经皮介入操作后30天内死亡。然而,对于7岁的非霍奇金淋巴瘤患者,降低胆红素水平的操作成功,随后给予了化疗;他在31天后因原发性疾病进展而死亡。由于合并疾病,置管时间在2天至60天之间。6例患者(16.7%)在手术风险降低后最终接受了胆囊切除术。2例患者(5.6%)接受了内镜逆行胰胆管造影术(ERCP)以从胆总管取出结石。18例患者(50%)从急性疾病中康复,在对照胆管造影后,随后拔除了导管。
在超声和透视引导下的经皮胆囊造瘘术对于患有急性胆囊炎的重症患者而言,是一种经济有效、易于实施且可靠的操作,并发症少,成功率高。